20981484|t|Site-activated chelators derived from anti-Parkinson drug rasagiline as a potential safer and more effective approach to the treatment of Alzheimer's disease.
20981484|a|chelators can modulate beta-amyloid accumulation, protect against tau hyperphosphorylation, and block metal-related oxidative stress, and thereby hold considerable promise as effective anti-AD drugs. At present, a growing interest is focusing on increasing the efficacy and targeting of chelators through drug design. To this end, we have developed a new class of multifunctional prochelators from three FDA- approved drugs rasagiline, rivastigmine, and donepezil or tacrine. HLA20 A was designed by merging the important pharmacophores of rasagiline, rivastigmine, and donepezil into our newly developed multifunctional chelator HLA20. M30D was constructed using the key pharmacophoric moieties from rasagiline, rivastigmine, and tacrine. Experiments showed that both compounds possess potent anti-acetylcholinesterase (AChE) activity in vitro with weak inhibition of butyrylcholinesterase (BuChE), and without significant metal-binding activity. M30D was found also to be a highly potent MAO A inhibitor with moderate inhibition of MAO B in vitro. Both HLA20 and M30D can be activated by inhibition of AChE to release active chelators HLA20 and M30, respectively. HLA20 and M30 have been shown to be able to modulate amyloid precursor protein regulation and beta-amyloid reduction, suppress oxidative stress, and passivate excess metal ions (Fe, Cu, and Zn). Compared with the activated chelator HLA20 or M30, both HLA20A and M30D exhibited lower cytotoxicity in SH-SY5Y neuroblastoma cells, substantiating the prochelator strategy for minimizing toxicity associated with poor targeted chelators.
20981484	43	57	Parkinson drug	Disease	MESH:D010302
20981484	58	68	rasagiline	Chemical	MESH:C031967
20981484	138	157	Alzheimer's disease	Disease	MESH:D000544
20981484	261	266	metal	Chemical	MESH:D008670
20981484	349	351	AD	Disease	MESH:D000544
20981484	583	593	rasagiline	Chemical	MESH:C031967
20981484	595	607	rivastigmine	Chemical	MESH:D000068836
20981484	613	622	donepezil	Chemical	MESH:D000077265
20981484	626	633	tacrine	Chemical	MESH:D013619
20981484	699	709	rasagiline	Chemical	MESH:C031967
20981484	711	723	rivastigmine	Chemical	MESH:D000068836
20981484	729	738	donepezil	Chemical	MESH:D000077265
20981484	796	800	M30D	ProteinMutation	tmVar:p|SUB|M|30|D;HGVS:p.M30D;VariantGroup:0;CorrespondingGene:43;CorrespondingSpecies:9606
20981484	860	870	rasagiline	Chemical	MESH:C031967
20981484	872	884	rivastigmine	Chemical	MESH:D000068836
20981484	890	897	tacrine	Chemical	MESH:D013619
20981484	958	978	acetylcholinesterase	Gene	43
20981484	980	984	AChE	Gene	43
20981484	1028	1049	butyrylcholinesterase	Gene	590
20981484	1051	1056	BuChE	Gene	590
20981484	1083	1088	metal	Chemical	MESH:D008670
20981484	1107	1111	M30D	ProteinMutation	tmVar:p|SUB|M|30|D;HGVS:p.M30D;VariantGroup:0;CorrespondingGene:43;CorrespondingSpecies:9606
20981484	1149	1154	MAO A	Gene	4128
20981484	1193	1198	MAO B	Gene	4129
20981484	1224	1228	M30D	ProteinMutation	tmVar:p|SUB|M|30|D;HGVS:p.M30D;VariantGroup:0;CorrespondingGene:43;CorrespondingSpecies:9606
20981484	1263	1267	AChE	Gene	43
20981484	1306	1309	M30	ProteinMutation	tmVar:p|Allele|M|30;VariantGroup:0;CorrespondingGene:43;CorrespondingSpecies:9606
20981484	1335	1338	M30	ProteinMutation	tmVar:p|Allele|M|30;VariantGroup:0;CorrespondingGene:43;CorrespondingSpecies:9606
20981484	1378	1403	amyloid precursor protein	Gene	351
20981484	1491	1496	metal	Chemical	MESH:D008670
20981484	1503	1505	Fe	Chemical	MESH:D007501
20981484	1507	1509	Cu	Chemical	MESH:D003300
20981484	1515	1517	Zn	Chemical	MESH:D015032
20981484	1566	1569	M30	ProteinMutation	tmVar:p|Allele|M|30;VariantGroup:0;CorrespondingGene:43;CorrespondingSpecies:9606
20981484	1587	1591	M30D	ProteinMutation	tmVar:p|SUB|M|30|D;HGVS:p.M30D;VariantGroup:0;CorrespondingGene:43;CorrespondingSpecies:9606
20981484	1608	1620	cytotoxicity	Disease	MESH:D064420
20981484	1624	1645	SH-SY5Y neuroblastoma	CellLine	CVCL:0019
20981484	1708	1716	toxicity	Disease	MESH:D064420
20981484	Positive_Correlation	MESH:C031967	HGVS:p.M30D;CorrespondingGene:43
20981484	Positive_Correlation	MESH:D000068836	HGVS:p.M30D;CorrespondingGene:43
20981484	Positive_Correlation	MESH:D007501	HGVS:p.M30D;CorrespondingGene:43
20981484	Positive_Correlation	CorrespondingGene:43;CorrespondingSpecies:9606;VariantGroup:0;tmVar:p	HGVS:p.M30D;CorrespondingGene:43
20981484	Positive_Correlation	MESH:D000077265	HGVS:p.M30D;CorrespondingGene:43
20981484	Negative_Correlation	MESH:C031967	MESH:D000544
20981484	Positive_Correlation	MESH:D008670	HGVS:p.M30D;CorrespondingGene:43
20981484	Positive_Correlation	MESH:D013619	HGVS:p.M30D;CorrespondingGene:43
20981484	Negative_Correlation	MESH:D064420	HGVS:p.M30D;CorrespondingGene:43
20981484	Association	MESH:D015032	CorrespondingGene:43;CorrespondingSpecies:9606;VariantGroup:0;tmVar:p
20981484	Negative_Correlation	MESH:C031967	MESH:D010302
20981484	Positive_Correlation	MESH:D015032	HGVS:p.M30D;CorrespondingGene:43
20981484	Association	MESH:D003300	CorrespondingGene:43;CorrespondingSpecies:9606;VariantGroup:0;tmVar:p
20981484	Association	MESH:D003300	HGVS:p.M30D;CorrespondingGene:43
20981484	Positive_Correlation	MESH:D007501	CorrespondingGene:43;CorrespondingSpecies:9606;VariantGroup:0;tmVar:p
20981484	Positive_Correlation	MESH:D008670	CorrespondingGene:43;CorrespondingSpecies:9606;VariantGroup:0;tmVar:p
20981484	Association	MESH:D064420	43

